The Nasdaq hasn't had a down month this year, but that's not stopping skeptics from piling onto these five companies.
News & Analysis: Affymax, Inc.
There's more than one way to see monster drops.
These five companies went the wrong way this past week.
Following these key steps will allow you to participate in what could be the greatest growth sector over the next decade.
Though it's had a few down days, the Dow is on a big upswing and big pharma is right alongside it.
Remember, investors, don't count those mysterious biotech pops before actual news confirms it.
Three earnings reports set the stage for an otherwise quiet week in the health-care sector.
This is a rocket ride you want no part of.
A look back at the biggest stories this week in biotech and what they mean for investors.
Are these three stocks about to make a large move?